@IndiGo6E please do help me put
Travelled more than 100 times, had a mistake in booking in myname when i look in during check in, now customer call saying you cant, even u have all the proof! Please do help me PNR- CCTU5K, IBV1UT
🚨In January, I warned that healthcare in India was about to become a gig economy. Many called me alarmist.
‼️Today, a Bengaluru startup, Tez Health, is offering doctors at home, ₹499 home injections and a "minimum bookings guarantee"!
🤡That is what we are about to normalize in urban India.
🙏To my fellow doctors, nurses and medical students, this is the "exact gig economy script" being run on us next.
🙏To every patient and family reading this, this is your living room being turned into the next dark store!
✅If you care about saving healthcare in this country, please share this and tag @MoHFW_INDIA, @NMC_IND, @CPCB_OFFICIAL, your state medical council, and your state pollution control board. They need to see this before the first preventable death makes it to a front page.
🥼Me and my team have investigated this startup and we write in detail about why this is a Pandora's box and dangerous for our country! 👇🏽
My friend who is a Radiologist, has secured Rank 1 in FET in Neurovascular intervention.
The Head of Neurointervention @NarayanaHealth@NHrudayalaya is apparently make his residents call my friend to not take up the seat because he prefers DM Neuro candidate!
What Nonsense?!
@DrRohanAcharya@NarayanaHealth@NHrudayalaya So thats what neurorad senior faculty shared the knowledge to the mentor of this program and now he is denying to share this to neurorad
Today is World Liver Day 2026.
Here are 8 things your liver actually wants you to know.
1
There is no such thing as a "liver detox."
Your liver runs phase I and II detoxification 24/7 on its own.
No juice cleanse, no milk thistle, no herbal detox speeds this up.
In fact several have caused liver injury - the opposite of the claim.
2
Alcohol has no safe dose.
Liver harm begins from the first drink.
The old "moderate drinking is protective" myth came from flawed studies contaminated by abstainer bias - now debunked by Mendelian randomization.
Zero ml is best.
3
"Natural" supplements are now a leading cause of acute liver failure.
Ashwagandha. Green tea extract. Garcinia. Kratom. High-dose turmeric. Giloy/Tinospora.
They dominate drug-induced liver injury registries across India, the US, and Europe.
Natural ≠ safe.
4
Coffee is genuinely liver-protective.
2–3 cups/day (caffeinated or decaf) lowers the risk of fibrosis, cirrhosis, and liver cancer.
One of the very few dietary interventions with real, replicated evidence.
5
Fatty liver (MASLD) now affects ~1 in 3 adults worldwide.
A 7–10% body-weight loss:
• clears Liver fat
• reduces inflammation
• can regress early fibrosis
No approved drug currently beats this. Your plate and feet are the first-line therapy.
6
Sugar-sweetened drinks independently cause fatty liver.
Fructose is metabolized almost entirely by the liver - straight into fat.
One daily soda raises MASLD risk even after adjusting for total calories.
Lesser is better.
7
Get vaccinated against hepatitis B. Get screened for HBV and HCV at least once in your lifetime.
HBV vaccine prevents >95% of chronic infection, cirrhosis, and liver cancer.
Hepatitis C is curable in 8-12 weeks with >95% success - but most carriers don't know they have it.
8
Exercise protects the liver independent of weight loss.
150 min/week moderate OR 75 min vigorous activity reduces liver fat and stiffness - even when the scale doesn't move.
Movement is "medicine".
🫂
PS: we also need a liver emoji
💊🧠 Can prasugrel-based single antiplatelet therapy offer a simpler option for distal aneurysm flow diversion?
In this multicenter real-world study, SAPT showed comparable angiographic occlusion to DAPT after treatment with the p48 MW HPC flow diverter, without a significant increase in thromboembolic or ischemic events. Hemorrhagic complications were seen only in the DAPT group, supporting continued interest in tailored antiplatelet strategies for selected patients. @AlexanderSirak1@SirakovStanimir@AbdallahAb48757
📖 Read more (open access): https://t.co/sLsyhizPm4
A positive MOG antibody result does not always mean MOGAD‼️
TRUE MOGAD Score helps neurologists worldwide estimate whether a positive MOG result is truly clinically meaningful.
Proud collaboration between @MayoClinic and @JohnsHopkins
Scan the QR code below to access the tool 👇🏽
Odisha lost a ₹70,000 crore mega steel project by ArcelorMittal Nippon Steel India to Andhra Pradesh.
This is not just a missed investment—it’s a failure of governance. Why couldn’t the BJP deliver what Odisha rightfully deserved?
#Odisha#AndhraPradesh#AMNSIndiaComesToAP
FAIMA strongly condemns the legal harassment of Dr. Sivaranjani Santosh for speaking out on public health issues. Doctors must be free to defend patient safety and scientific truth—any attempt to silence us threatens public health and our fundamental rights. We stand united!
#MedicalFreedom #PublicHealth #StandWithDoctors
#STROKE: First-in-human study to enable live visualization of intracranial, including stents, flow diverters & thrombectomy, without complications. https://t.co/Ts4XGDjmM3
Just Published
Anatomy of the Middle Meningeal Artery: Implications for Middle Meningeal Artery Embolization in Chronic Subdural Hematoma
https://t.co/sQnrgor8aQ
🚨 #ISC26 delivered BIG for stroke care. Multiple practice-important and promising trials across thrombosis, reperfusion, EVT, ICH, and neuroprotection 🏥🧠👇
🔹 OCEANIC-STROKE – Positive phase III: FXIa inhibition with asundexian reduced ischemic stroke in patients with non-cardioembolic stroke or high-risk TIA on antiplatelet therapy without increased major bleeding
🔹 OPTION – In patients with salvageable tissue, tenecteplase (4.5–24h) significantly improved 90-day excellent outcomes with higher sICH (2.8% vs 0%)
🔹 CHOICE-2 – Largest phase III trial of IA alteplase after successful EVT: higher excellent outcomes (mRS 0–1), no increase in sICH, NNT ≈ 7
🔹 FASTEST – rFVIIa for spontaneous ICH: promising early results in spot sign–positive patients treated <90 min
🔹 LAIS – Loberamisal (dual-target neuroprotection) within 48h for AIS (NIHSS 7–20): 13% absolute increase in excellent functional outcomes at 90 days
🔹 DISTALS – Tigertriever for distal occlusions: higher successful reperfusion at 24h without increased sICH
🔹 ORIENTA-MeVO – EVT for MeVO improved 90-day functional outcomes without excess sICH in a Chinese population
The stroke playbook is evolving in real time. 🔥
#Stroke #ISC26 #VascularNeurology #EVT #Tenecteplase #ICH #ClinicalTrials #AHAScience #StrokeResearch @StrokeAHA_ASA@AHAScience 🧠